1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Illinois >
  6. Tolmar Pharmaceuticals Acquires JATENZO

M&A Deal Summary

Tolmar Pharmaceuticals Acquires JATENZO

On October 28, 2022, Tolmar Pharmaceuticals acquired life science company JATENZO from Clarus Therapeutics

Acquisition Highlights
  • This is Tolmar Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Tolmar Pharmaceuticals’ 1st transaction in the United States.
  • This is Tolmar Pharmaceuticals’ 1st transaction in Illinois.

M&A Deal Summary
Date 2022-10-28
Target JATENZO
Sector Life Science
Buyer(s) Tolmar Pharmaceuticals
Sellers(s) Clarus Therapeutics
Deal Type Divestiture

Target

JATENZO

Northbrook, Illinois, United States
JATENZO is an oral softgel testosterone undecanoate for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone including primary hypogonadism and hypogonadotropic hypogonadism.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Tolmar Pharmaceuticals

Fort Collins, Colorado, United States
Category Company
Sector Life Science
DESCRIPTION

Tolmar Pharmaceuticals is a fully integrated pharmaceutical company focused on the innovative development, manufacturing, and commercialization of specialty pharmaceuticals across multiple therapeutic areas, including Urology. Tolmar Pharmaceuticals is based in Fort Collins, Colorado.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: Illinois M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2022 M&A 1 of 1

Seller(S) 1

SELLER

Clarus Therapeutics

Northbrook, Illinois, United States
Category Company
Sector Life Science
DESCRIPTION

Clarus Therapeutics is a pharmaceutical company developed and commercialized of oral testosterone replacement therapy. Clarus Therapeutics is based in Northbrook, Illinois.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: Illinois M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2022 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal